3 Reasons Trump ’s Plan to Privatize the International Space Station Won’t (and Shouldn’t) Happen

Dabbling in real estate and looking for a way to invest hundreds of millions of dollars with virtually no chance of return? Then the International Space Station (ISS) is for you. Discontinuing funding for space station operations after 2024 and turning the job over to the private sector after that is something the Trump Administration is currently contemplating, the Washington Post reports. The good news is this will surely never happen. The bad news is that the White House is even considering a plan that fails on so many levels. Here are the three big ones. Privatizing the Space Station is a fiscal loser The International Space Station was first proposed in 1984 by then-President Ronald Reagan. Back then it was called the Freedom Space Station, and back then it was supposed to cost just $8 billion ($19 billion in 2017 dollars). Things haven’t worked out quite that way, with $100 billion the generally accepted figure for what the U.S. has spent on the station so far — and many analysts putting the figure closer to $150 billion, once you take support costs into consideration. Just maintaining the completed station costs up to $4 billion per year — big money for a space agency whose overall annual budget is less than $20 billion. So it’s an investment that the government might well want to unload. But as with all distressed properties, the question is, who would want it? The station was never intended to be a money-making operation, and after more than ...
Source: TIME: Science - Category: Science Authors: Tags: Uncategorized budgets Government international space station NASA Science trump Source Type: news

Related Links:

Authors: Masouris I, Klein M, Ködel U Abstract INTRODUCTION: Central nervous system (CNS) infections can be life-threatening and are often associated with disabling sequelae. One important factor in most CNS infections is a timely pathogen-specific treatment. The diagnostic methods available, however, do not always reach a satisfying sensitivity and specificity. In these cases, there is need for additional diagnostic biomarkers. Chemokines represent potential candidates as biomarkers, since they are an important pillar of the host immune response. The aim of this review is to discuss the diagnostic potential o...
Source: Expert Review of Anti-Infective Therapy - Category: Infectious Diseases Tags: Expert Rev Anti Infect Ther Source Type: research
Publication date: Available online 1 June 2020Source: Biotechnology ReportsAuthor(s): Bouchra Louasté, Noureddine Eloutassi
Source: Biotechnology Reports - Category: Biotechnology Source Type: research
Publication date: Available online 1 June 2020Source: Biocatalysis and Agricultural BiotechnologyAuthor(s): S.R. Saranya, Sudhakaran R
Source: Biocatalysis and Agricultural Biotechnology - Category: Biotechnology Source Type: research
Publication date: Available online 1 June 2020Source: Biocatalysis and Agricultural BiotechnologyAuthor(s): Jee Yin Cheong, Mustafa Muskhazli, Abd Aziz Nor Azwady, Siti Aqlima Ahmad, Azleen Ahmad Adli
Source: Biocatalysis and Agricultural Biotechnology - Category: Biotechnology Source Type: research
OHSU clinicians want to get the word out that it's safe to come in for care.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Discussion and conclusions: M. sirikitiae is a source of cytotoxic lignans and alkaloids. Among the cytotoxic compounds, magnone A and 6-methoxymarcanine A are potentially useful lead compounds for the further development of anticancer agents because of their selective inhibitory effects on cancer cell lines. PMID: 32478640 [PubMed - as supplied by publisher]
Source: Pharmaceutical Biology - Category: Drugs & Pharmacology Tags: Pharm Biol Source Type: research
Discussion and conclusions: EXD demonstrated neuroprotective effects and improved depression-like behaviour in mice. Further research should be focussed on the mechanism of the active components in EXD. PMID: 32476554 [PubMed - in process]
Source: Pharmaceutical Biology - Category: Drugs & Pharmacology Tags: Pharm Biol Source Type: research
This study examined the antihypoxia effects of SPM in vivo.Materials and methods: The dried and pulverised of SPM was extracted from root crude drug with 70% ethanol with ultrasound. Male Sprague-Dawley rats were divided into three groups (n = 10): normal group, hypoxia group (altitude of 4260 m), and hypoxia + SPM group (altitude of 4260 m, SPM of 1.0 g/kg/day). The experiment persisted for 4 weeks. The mean pulmonary arterial pressure (mPAP), hypoxia-inducible factor-1α (HIF-1α) mRNA, and lung pathology were analysed using pulmonary artery pressure recorde...
Source: Pharmaceutical Biology - Category: Drugs & Pharmacology Tags: Pharm Biol Source Type: research
Authors: Qian X, Wang Z, Ning J, Qin C, Gao L, He N, Lin D, Zhou Z, Li G Abstract Context: Persimmon tannin (extract of Diospyros kaki L.f [Ebenaceae]) and Aloe gel (extract of Aloe vera (L.) Burm.f. [Asphodelaceae]) are known as anti-radiation agents. However, radiation resistance of the persimmon tannin-Aloe gel composite remains inconclusive.Objective: To investigate the capacity of the persimmon tannin-Aloe gel composite to protect against ionising radiation at the cellular level.Materials and methods: HaCaT (human epidermal keratinocytes) cells were pre-treated with PT-A-1 (the mass ratio of persimmon tannin a...
Source: Pharmaceutical Biology - Category: Drugs & Pharmacology Tags: Pharm Biol Source Type: research
Conclusion: These results show PSD, R13, and PSA are good candidates as natural products for use in the treatment of lung cancer. Potential signalling pathways and protein targets need to be further validated. The application of the drug combination approach also provides a therapeutic strategy for cancer. PMID: 32476531 [PubMed - in process]
Source: Pharmaceutical Biology - Category: Drugs & Pharmacology Tags: Pharm Biol Source Type: research
More News: American Health | Budgets | Contracts | Environmental Health | Funding | Government | Legislation | Lessons | Obama | Physics | Politics | Russia Health | Science | Study | Trump | Universities | USA Health